Anesthetic management of an elderly COVID-19 patient with pulmonary thromboembolism for hip surgery - A case report -

Heo, Min Hee; Choi, Hak-Ki; Kim, Ji Yeon; Kim, Kyung Woo; Lee, S.I.; Kim, Kyung‐Tae; Park, Jang Su; Choi, Won Joo; Kim, JunHyun

doi:10.17085/apm.23009

Cited by 1 publication

(1 citation statement)

References 16 publications

(32 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As the elderly population continues to grow, the global frequency of hip surgery is progressively increasing [1]. According to prior research, over 1.5 million patients worldwide are diagnosed with hip fractures annually [2].…”

Section: Introductionmentioning

confidence: 99%

Effectiveness of Intravenous Non-Opioid Analgesics for Postoperative Pain Management of in Patients Undergoing Hip Surgery: A Systematic Review and Meta-Analysis

Chang,

Lee,

Kang

et al. 2023

Medicina

View full text Add to dashboard Cite

Background and Objectives: Intravenous (IV) non-opioid analgesics (NOAs) have been extensively investigated as a multimodal analgesic strategy for the management of acute pain after hip surgery. This pair-wise meta-analysis examined IV NOA effects following hip surgery. Materials and Methods: A systematic search of the MEDLINE (PUBMED), Embase, and Cochrane Library databases was performed for studies investigating the effect of IV NOA for postoperative pain management following hip surgery up to 7 June 2023. We compared in-admission opioid use, postoperative VAS (visual analogue scale) score, hospital stay duration, and opioid-related adverse events between IV NOA and control groups. Results: Seven studies were included with a total of 953 patients who underwent hip surgery. Of these, 478 underwent IV NOA treatment, and 475 did not. The IV NOA groups had lower opioid use within 24-h following hip surgery (SMD, −0.48; 95% CI, −0.66 to −0.30; p < 0.01), lower VAS score (SMD, −0.47; 95% CI, −0.79 to −0.16; p < 0.01), shorter hospital stay (SMD, −0.28; 95% CI, −0.44 to −0.12; p < 0.01), and lower incidence of nausea and vomiting (OR, 0.32; 95% CI, 0.15 to 0.67; p < 0.01) compared with the control groups. Conclusions: This meta-analysis demonstrated that IV NOA administration following hip surgery may have more favorable postoperative outcomes than those in control groups.

show abstract

Section: Introductionmentioning

confidence: 99%